These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7015433)

  • 1. High-dose methotrexate and cis-platinum in the treatment of recurrent head and neck cancer.
    Jacobs C
    Recent Results Cancer Res; 1981; 76():290-5. PubMed ID: 7015433
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum.
    Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A
    Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.
    Davis S; Kessler W
    Cancer Chemother Pharmacol; 1979; 3(1):57-9. PubMed ID: 93988
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study.
    Jacobs C; Meyers F; Hendrickson C; Kohler M; Carter S
    Cancer; 1983 Nov; 52(9):1563-9. PubMed ID: 6352004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck.
    Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P
    Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
    Vogl SE; Schoenfeld DA; Kaplan BH; Lerner HJ; Engstrom PF; Horton J
    Cancer; 1985 Aug; 56(3):432-42. PubMed ID: 2408735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
    Jahnke V
    HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized phase III trial of cisplatinum, methotrexate, cisplatinum + methotrexate, and cisplatinum + 5-fluoro-uracil in end-stage head and neck cancer.
    Campbell JB; Dorman EB; McCormick M; Miles J; Morton RP; Rugman F; Stell PM; Stoney PJ; Vaughan ED; Wilson JA
    Acta Otolaryngol; 1987; 103(5-6):519-28. PubMed ID: 3303823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A; Cummings G; Al-Sarraf M
    Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
    von Heyden HW; Schröder M; Scherpe A; Borghardt J; Beyer JH; Nagel GA; Gerhartz H; Foth B; Kastenbauer E; Westerhausen M
    Recent Results Cancer Res; 1985; 98():148-52. PubMed ID: 2412266
    [No Abstract]   [Full Text] [Related]  

  • 12. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.
    Machiels JP; Haddad RI; Fayette J; Licitra LF; Tahara M; Vermorken JB; Clement PM; Gauler T; Cupissol D; Grau JJ; Guigay J; Caponigro F; de Castro G; de Souza Viana L; Keilholz U; Del Campo JM; Cong XJ; Ehrnrooth E; Cohen EE;
    Lancet Oncol; 2015 May; 16(5):583-94. PubMed ID: 25892145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck.
    Hong WK; Schaefer S; Issell B; Cummings C; Luedke D; Bromer R; Fofonoff S; D'Aoust J; Shapshay S; Welch J; Levin E; Vincent M; Vaughan C; Strong S
    Cancer; 1983 Jul; 52(2):206-10. PubMed ID: 6190545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of treatment of head and neck carcinoma with high dose methotrexate.
    Bell R; Sullivan JR; Fleming WB; Grey PA; Millar HS
    Clin Exp Pharmacol Physiol Suppl; 1979; 5():23-7. PubMed ID: 400970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of methotrexate and 5-FU for recurrent head and neck cancer.
    Jacobs C
    Cancer Treat Rep; 1982 Nov; 66(11):1925-8. PubMed ID: 6754074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy.
    Machiels JP; Van Maanen A; Vandenbulcke JM; Filleul B; Seront E; Henry S; D'Hondt L; Lonchay C; Holbrechts S; Boegner P; Brohee D; Dequanter D; Louviaux I; Sautois B; Whenham N; Berchem G; Vanderschueren B; Fontaine C; Schmitz S; Gillain A; Schoonjans J; Rottey S
    Oncologist; 2016 Dec; 21(12):1416-e17. PubMed ID: 27903924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancer.
    Chang PM; Teng HW; Chen PM; Chang SY; Chu PY; Tsai TL; Tai SK; Wang YF; Huang JL; Yang MH
    J Chin Med Assoc; 2008 Jul; 71(7):336-41. PubMed ID: 18653395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for cytostatic therapy of recurrent cancer].
    Schröder M; Stennert E; von Heyden HW; Scherpe A
    HNO; 1984 Jun; 32(6):245-8. PubMed ID: 6206035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.